Cargando…

Defining the pediatric response to SARS-CoV-2 variants

The global population has been severely affected by the coronavirus disease 2019 (COVID-19) pandemic, however, with older age identified as a risk factor, children have been underprioritized. This article discusses the factors contributing to the less severe response observed in children following i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Reanne M., Bowen, Asha C., Blyth, Christopher C., Imrie, Allison, Kollmann, Tobias R., Stick, Stephen M., Kicic, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248061/ https://www.ncbi.nlm.nih.gov/pubmed/37304275 http://dx.doi.org/10.3389/fimmu.2023.1200456

Ejemplares similares

Rhinovirus Infection Is Associated With Airway Epithelial Cell Necrosis and Inflammation via Interleukin-1 in Young Children With Cystic Fibrosis
por: Montgomery, Samuel T., et al.
Publicado: (2020)

An adapted novel flow cytometry methodology to delineate types of cell death in airway epithelial cells
por: Montgomery, Samuel T., et al.
Publicado: (2020)

Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells
por: Zhu, Yanshan, et al.
Publicado: (2022)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

Pre-clinical models to define correlates of protection for SARS-CoV-2
por: Brady, Caolann, et al.
Publicado: (2023)

Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?
por: Ling, Kak-Ming, et al.
Publicado: (2023)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Macrophages and γδ T cells interplay during SARS-CoV-2 variants infection
por: Atmeh, Perla Abou, et al.
Publicado: (2022)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
por: Laucirica, Daniel R., et al.
Publicado: (2022)

Variation between Populations in the Innate Immune Response to Vaccine Adjuvants
por: Kollmann, Tobias R.
Publicado: (2013)

The use of non-bronchoscopic brushings to study the paediatric airway
por: Lane, Catherine, et al.
Publicado: (2005)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
por: Wu, Jiajing, et al.
Publicado: (2021)

SARS-CoV-2’s Variants of Concern: A Brief Characterization
por: Scovino, Aline Miranda, et al.
Publicado: (2022)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022)

Editorial: SARS-CoV-2 variants, B lymphocytes, and autoreactivity
por: Radic, Marko Z., et al.
Publicado: (2023)

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants
por: Isaacs, Ariel, et al.
Publicado: (2022)

Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity
por: Laucirica, Daniel R., et al.
Publicado: (2020)

Rhinovirus Infection Drives Complex Host Airway Molecular Responses in Children With Cystic Fibrosis
por: Ling, Kak-Ming, et al.
Publicado: (2020)

Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity
por: Wu, Jun, et al.
Publicado: (2021)

Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation
por: Vaitekenas, Andrew, et al.
Publicado: (2021)

HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility
por: Behairy, Mohammed Y., et al.
Publicado: (2022)

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
por: Liu, Haolin, et al.
Publicado: (2022)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Differential activation of human neutrophils by SARS-CoV-2 variants of concern
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
por: Thompson, Robin N., et al.
Publicado: (2023)

An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
por: Khan, Muhammad Zafar Irshad, et al.
Publicado: (2022)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

The Role of Environmental Factors in Modulating Immune Responses in Early Life
por: MacGillivray, Duncan M., et al.
Publicado: (2014)

Successful establishment of primary small airway cell cultures in human lung transplantation
por: Banerjee, Balarka, et al.
Publicado: (2009)

Primary Nasal Epithelial Cells as a Surrogate Cell Culture Model for Type-II Alveolar Cells to Study ABCA-3 Deficiency
por: Shaw, Nicole C., et al.
Publicado: (2022)

Understanding the Ontogeny of the Immune System to Promote Immune-Mediated Health for Life
por: Marchant, Arnaud, et al.
Publicado: (2015)

SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant
por: Garcia, Cédric, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
por: Ling, Kak-Ming, et al.
Publicado: (2018)

Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
por: Trend, Stephanie, et al.
Publicado: (2018)

Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis
por: Ng, Renee N., et al.
Publicado: (2021)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6hkefghbmf1u26tp543roci6lb